InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,728.80
(
0.00%
)
US TECH 100
19,498.00
(
0.00%
)
Dow Jones
42,052.19
(
0.00%
)
Brent Oil
74.78
(
0.94%
)
Bitcoin
68,536.17
(
-0.30%
)
Post# of 53517
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

psyched

Send PM Follow Ignore
Followers 0
Posts 72
Boards Moderated 0
Alias Born 04/28/2021

psyched

Re: None

Wednesday, 02/01/2023 11:00:00 AM

Wednesday, February 01, 2023 11:00:00 AM

Post# of 53517
$CYBN Cybin Announces Approval of First-in-Human Dosing of its Proprietary DMT Molecule CYB004. This is the first trial ever evaluating deuterated DMT in humans! https://ir.cybin.com/investors/news/news-details/2023/Cybin-Announces-Approval-of-First-in-Human-Dosing-of-its-Proprietary-DMT-Molecule-CYB004/default.aspx
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up